Lipophilic chemical exposure as a cause of type 2 diabetes (T2D)

Reviews on Environmental Health

Volumn 28, Issue 1, 2013, Pages 9-20

  Zeliger, Harold I ^a  

^a Zeliger Chemical Environmental and Toxicological Services   (United States)

Author keywords

Diabetes; Environmental disease; Environmental illness; Toxic chemical mixtures; Type 2 diabetes

Indexed keywords

ADIPOSE TISSUE; CHEMICALLY INDUCED DISORDER; CLUSTER ANALYSIS; DRUG EFFECT; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; POLLUTANT; REVIEW;

ADIPOSE TISSUE; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL POLLUTANTS; HUMANS;

NICOTIANA TABACUM;

EID: 84879033326     PISSN: 00487554     EISSN: None     Source Type: Journal    
DOI: 10.1515/reveh-2012-0031     Document Type: Review

References (173)

1. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010;39:481-97.
2. Ginter E, Simko V. Diabetes type 2 pandemic in the 21st century. Bratisl Lek Listy 2010;111:134-7.
3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates for the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Prct 2010;87:4-14.
4. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010;8:29-41.
5. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006;29:2114-6.
6. Rene BJ, Bunce R, Bunce NJ. Linking dioxins to diabetes: Epidemiology and biologic plausibility. Environ Heath Perspect 2002;110:853-8.
7. Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes. Diabetes Care 2006;29:1638-44.
8. Lee DH, Steffes MW, Sjoden A, Jones RS, Needham LL, et al. Low dose of some persistent organic pollutants predicts type 2 diabetes: A nested case-control study. Environ Health Perspect 2010;118:1235-42.
9. Yu GW, Laseter J, Mylander C. Persistent organic pollutants in serum and several different fat compartments in humans. J Environ Public Health 2011;2011:417980.
10. Henriksen GL, Ketchum NS, Michalek JE, Swaby JA. Serum dioxin and diabetes mellitus in veterans of operation Ranch Hand. Epidemiology 1997;8:252-8.
11. Carpenter DO. Environmental contaminants as risk factors for developing diabetes. Rev Environ Health 2008;23:59-74.
12. Thayer KA, Heindel JJ, Bucher JR, Gallo MA. Role of environmental chemicals in diabetes and obesity: A National Toxicology Program workshop report. Environ Health Perspect 2012;120:779-89.
13. Dijekema MBA, Mallant SF, Gerhring U, van den Hurk K, Alssema M, et al. Long-term exposure to traffic-related air pollution and type 2 diabetes prevalence in a cross-sectional screening-study in the Netherlands. Environ Health 2011;10:76.
14. Brook RD, Jerrett M, Brook JR, Bard RL, Finkelstein MM. The relationship between diabetes mellitus and traffic-related air pollution. J Occup Environ Med 2008;50:32-8.
15. Shankar A, Teppala S. Relationship between urinary bisphenol a levels and diabetes mellitus. J Clin Endocrinol Metab 2011;96:3822-6.
16. Silver MK, O'Neill MS, Sowers MR, Park SK. Urinary bisphenol a and type-2 diabetes in U.S. adults: Data from MNANES 2-3-2008. PLos One 2011;6:e26868.
17. Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect 2007;115:876-82.
18. Ko KP, Min H, Ahn Y, Park SJ, Cim CS, et al. A prospective study investigating the association between environmental tobacco smoke exposure and the incidence of type 2 diabetes in never smokers. Ann Epidemiol 2011;21:42-7.
19. Kowall B, Rathmann W. Strassburger K, Heier M, Holle R, et al. Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: The KORA S4/F4 cohort study. Eur J Epideniol 2010;25:393-402.
20. Zhang L, Curham GC, Hu FB, Rimm EB, Forman JP. Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care 2012;34:892-97.
21. Doherty SP, Grabowski J, Hoffman C, NG SP, Zelikoff JT. Early life insult from cigarette smoke may be predictive of chronic diseases later in life. Biomarkers 2009;14:97-101.
22. Abbasi A, Corpeleijn E, Peelen LM, Gansevoort RT, de Jong PE, et al. External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: The PREVEND study. Eur J Epidemiol 2012;27:47-52.
23. Lim JS, Lee DH, Jacobs DR Jr. Association of brominated flame retardants with diabetes and metabolic syndrome in the U.S. population, 2003-2004. Diabetes Care 2008;31:1802-7.
24. Xu Y, Cohen-Hubal EA, Little JC. Predicting residential exposure to phthalate plasticizer emitted from vinyl flooring: Sensitivity, uncertainty, and implications for biomonitoring. Environ Health Perspect 2010;118:253-8.
25. Koo HJ, Lee BM. Estimated exposure to phthalates in cosmetics and risk assessment. J Toxicol Environ Health A 2004;67: 1901-14.
26. Koniecki D, Wang R, Moody RP, Zhu J. Phthalates in cosmetic and personal care products: Concentrations and possible dermal exposure. Environ Res 2011;111:329-6.
27. Schettler T. Human exposure to phthalates via consumer products. Int J Androl 2006;29:181-5.
28. Santodonato J. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: Relationship to carcinogenicity. Chemosphere 1997;34:835-48.
29. Liao C, Kannan K. Widespread occurrence of bisphenol a in paper and paper products: Implications for human exposure. Environ Sci Technol 2011;45:9372-9.
30. Liao C, Kannan K. High levels of bisphenol a in paper currencies from several countries, and implications for dermal exposure. Environ Sci Techol 2011;45:6761-8.
31. Cousins LT, Staples CA, Klecka GM, Mackay D. A multimedia assessment of the environmental fate of bisphenol A. Hum Ecol Risk Assess 2002;8:1107-35.
32. Lockwood AH. Diabetes and air pollution. Diabetes Care 2002;25:1487.
33. Tillett T. Traffic trouble: Study links diabetes to vehicular pollution. Environ Health Perspect 2010;118:a399.
34. Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, et al. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: The NLCS-AIR study. Res Rep Health Eff Inst 2009;139:73-89.
35. Coogan PF, White LF, Jerrett M, Brook RD, Su JG, et al. Air pollution and incidence of hypertension and diabetes mellitus in black women living in Los Angeles. Circulation 2012;125: 767-72.
36. Kramer U, Herder C, Sugiri D, Strassburger K, Schikowski T, et al. Traffic-related air pollution and incident type 2 diabetes: Results from the SALIA cohort study. Environ Health Perspect 2010;118:1273-9.
37. Sun Q, Yue P, Deiulis JA, Lumeng CN, Kampfrath T, et al. Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity. Circulation 2009;199:538-46.
38. Bhatnagar A. Could dirty air cause diabetes ? Circulation 2009;119:492-4.
39. Houston TK, Person SD, Pletcher MJ, Liu K, Iribarren C, et al. Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. Br Med J 2006;332:1064-9.
40. Joshi SK, Shrestha S. Diabetes mellitus: A review of its association with different environmental factors. Kathmandu Univ Med J 2010;8:109-15.
41. Longnecker MP, Daniels JL. Environmental contaminants as etiologic factors for diabetes. Environ Health Perspect 2001;109:871-6.
42. Del Razo LM, Garcia-Vargas GG, Valenzuela OL, Castallanos EH, Sanchez-Pena LC, et al. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: A crosssectional study in the Zimapan and Lagunera regions of Mexico. Environ Health 2011;10:33.
43. Elobeid MA, Brock DW, Allison DB, Padilla MA, Ruden DM. Endocrine disruptors and obesity: An examination of selected persistent organic pollutants in the NHANES 1999-2002 data. Int J Environ Res Public Health 2010;7:2988-3005.
44. Karpeta A, Gregoraszcczuk E. Mixture of dominant PBDE congeners (BDE-47,-99,-100 and-209 at levels noted in human blood dramatically enhances progesterone secretion by ovarian follicles. Endocr Regul 2010;44:49-55.
45. Tiido T, Rignell-Hydbom A, Jonsson B, Giwercman YL, Rylander L, et al. Exposure to persistent organic pollutants associates with human sperm Y:X chromosome ratio. Hum Reprod 2005;20:1903-9.
46. Pocar P, Brevini TAL, Fischer B, Gandolfi F. The impact of endocrine disruptors on oocyte competence. Reproduction 2003;125:313-25.
47. Gallo MV, Schell LM, DeCaprio AP, Jacobs A. Levels of persistent organic pollutant and their predictors among young adults. Chemosphere 2011;83:1374-82.
48. Cordu N, Schymura MJ, Nogotia S, Rej R, Carpenter DO. Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult native Americans. Environ Health Perspect 2007;115:1442-7.
49. Lee DH, Lind PM, Jacobs DR Jr., Salihovic S, van Bavel B, et al. Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: The prospective investigation of the vasculature in Uppsala seniors (PIVUS) study. Diabetes Care 2011; 34:1778-84.
50. Philibert A, Schwartz H, Mergler D. An exploratory study of diabetes in First Nation community with respect to the serum concentrations of p,p ′-DDE and PCBs and fish consumption. In J Environ Res Public Health 2009;6:3179-89.
51. Lee DH, Lee IK, Porta M, Steffes M, Jacobs DR Jr. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: Results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 2007;50:1841-51.
52. Zeliger HI. Toxic effects of chemical mixtures. Arch Environ Health 2003;58:23-9.
53. Zeliger HI, Pan Y, Rea WJ. Predicting co-morbidities in chemically sensitive individuals from exhaled breath analysis. Interdiscip Toxicol 2012;5:123-6.
54. Porta M. Persistent organic pollutants and the burden of diabetes. Lancet 2006;368:558-9.
55. Lim S, Cho YM, Park KS, Lee HK. Persistent organic pollutants, mitochondrial dysfunction, and metabolic syndrome. Ann NY Acad Sci 2010;1201:166-76.
56. Persky V, Piokowski J, Turyk M, Freels S, Chatterton R Jr., et al. Associations of polychlorinated biphenyl exposure and endogenous hormones with diabetes in post-menopausal women previously employed at a capacitor manufacturing plant. Environ Res 2011;111:817-24.
57. Turyk M, Anderson HA, Knobeloch L, Imm P, Persky VW. Prevalence of diabetes and body budens of polychlorinated biphenyls, polybrominated diphenyl ethers, and p,p ′-diphenyldichloroethane in Great Lakes sport fish consumers. Chemosphere 2009;75:674-9.
58. Rignell-Hydbom A, Lidfeldt J, Kiviranta H, Rantakokko R, Samsioe G, et al. Exposure to p,p ′-DDE: A risk factor for type 2 diabetes. PLoS One 2009;4:e7503.
59. Turyk M, Anderson HA, Knobeloch L, Imm P, Persky VW. Organochlorine exposure and incidence of diabetes in a cohort of Great Lakes sport fish consumers. Environ Health Perspect 2009;117:1076-82.
60. Ukropec J, Radikova Z, Huckova M, Koska J, Kocan A, et al. High prevalence of prediabetes in a population exposed to high levels of an organochlorine cocktail. Diabetologia 2010;53:899-906.
61. Lee DH. Persistent organic pollutants and obesity-related metabolic dysfunction: Focusing on type 2 diabetes. Epidemiol Health 2012;34:e2012002.
62. Bertazzi PA, Consonni D, Bachetti S, Rubagotti M, Baccarelli A, et al. Health effects of dioxin exposure: A 20-year mortality study. Am J Epidemiol 2001;153:1031-44.
63. Lorber M. Exposure of Americans to polybrominated diphenyl ethers. J Expo Sci Environ Epidemiol 2008;18:2-19.
64. Vasiliu O, Cameron L, Gardiner J, Deguire P, Karmaus W. Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 2006;17:352-9.
65. Baselt RC. Disposition of toxic drugs and chemicals in man, 5th ed. Foster City, CA: Chemical Toxicology Institute, 2000.
66. Culver Al, Ockene IS, Balasubramanian R, Olenddzki B, Sepavich DM, Wachawski-Wende J, et al. Statin use and risk of diabetes mellitus in postmenopausal women in the women's health initiative. Arch Int Med 2012;172:144-52.
67. Joshi HT, Fakes MG, Seajuddin ATM. Differentiation of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors by their relative lipophilicity. Pharm Pharmacol Commun 1999;5:269-71.
68. Zeliger HI. Statin use and risk of diabetes. Arch Int Med 2012;172:986-97.
69. Kim MJ, Marchand P, Henegar C, Antignac JP, Alili R, et al. Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss. Environ Health Perspect 2011;119:377-83.
70. Kouznetsova M, Huang X, Ma J, Lessner L, Carpenter DO. Increased rate of hospitalization for diabetes and residential proximity of hazardous waste sites. Environ Health Perspect 2007;115:75-9.
71. Mullerova D, Kopecky J. White adipose tissue: Storage and effector site for environmental pollutants. Physiol Res 2007;56:375-81.
72. Covaci A, Boer J, Ryan JJ, Voorspoels S, Schepens P. Distribution of organobrominated and organochlorinated contaminants in Belgian human adipose tissue. Environ Res 2002;88:210-8.
73. Li Y, Jiang X, Lan K, Jiang Q. Comparative single-and multiple-dose pharmacokinetics of rosuvastin following oral administration in Chinese volunteers. Eur J Drug Metab Pharmacokinet 2009;34:221-7.
74. Gopalagowda BH, Cutchins C, Cutchins DC, Peins AN. Alternate day rosuvastatin, an underutilized option in statin intolerant hyperlipidemic patients: A case report and literature review. Tenn Med 2011;104:49-51.
75. Zeliger HI. Human toxicology of chemical mixtures, 2nd ed. London: Elsevier, 2012:8,9.
76. Rea WJ. Chemical sensitivity, vol 1. Boca Raton, FL: Lewis Publishers, 1992:52-3.
77. Alessio L. Multiple exposures to solvents in the workplace. Int Arch Occup Environ Health 1996;69:1-4.
78. Witte I, Jacobi H, Juhl-Strauss U. Correlation of synergistic cytotoxic effects of environmental chemicals in human fibroblasts and their lipophilicity. Chemosphere 1995;31:4041-9.
79. Kitagawa S, Li H, Sato S. Skin permeation of parabens in excised guinea pig dorsal skin, its modification by penetration enhancers and their relationship with n-octanol/water partition coefficients. Chem Pharm Bull (Tokyo) 1997;45:1354-7.
80. Manganaro AM. Review of transmucosal drug delivery. Mil Med 1997;162:27-30.
81. Ghafourian R, Samaras EG, Brooks JD, Riviere JE. Modeling the effect of mixture components on permeation through skin. Int J Pharm 2010;398:28-32.
82. Pohanish RP. Sittig's handbook of toxic and hazardous chemicals and carcinogens, 6th ed. London: Elsevier, 2012.
83. Zeliger HI. Human toxicology of chemical mixtures, 2nd ed. London: Elsevier, 2012:40,41.
84. Zeliger HI. Unexplained cancer clusters: Common threads. Arch Environ Health 2004;59:172-6.
85. Consonni D, Pesatori AC, Zocchetti C, Sindaco R, D'Oro LC, et al. Mortality in a population exposed to dioxin after the Seveso, Italy accident in 1976: 25 years of follow-up. Am J Epidemiol 2008;167:847-58.
86. Wang SL, Tsai PC, Yang CY, Guo Y. Increased risk of diabetes and polychlorinated biphenyls and dioxins. Diabetes Care 2008;31:1574-9.
87. Cox S, Niskar AS, Narayan KM, Marcus M. Prevalence of self reported diabetes and exposure to organochlorine pesticides among Mexican Americans: Health and nutrition examination survey, 1982-1984, Environ Health Perspect 2007;115:1747-52.
88. Chiasson JL, Rabasa-Lhoret R. Prevention of type 2 diabetes, Insulin resistance and beta-cell function. Diabetes 2004;53:S34-8.
89. Nokoff NJ, Rewers M, Cree-Green M. The interplay of autoimmunity and insulin resistance in type 1 diabetes. Discov Med 2012;13:115-22.
90. Lee DH, Steffes MW, Jacobs DR. Positive associations of serum concentration of polychlorinated biphenyls or organochlorine pesticides with self-reported arthritis, especially rheumatoid type in women. Environ Health Perspect 2007;115:883-8.
91. Ha MN, Lee DH, Jacobs DR. Association betweens serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: Results from the National Health and Nutrition Examination Survey, 1999-2002. Environ Health Perspect 2007;115:1204-9.
92. Hertz-Picciotto I, Park HY, Dostal M, Kocan A, Trnovec Y, et al. Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic Clin Pharmacol Toxicol 2008;102:146-54.
93. Zhou H, Wu H, Liao C, Diao X, Zhen J, et al. Toxicology mechanism of the persistent organic pollutants (POPs) in fish through AhR pathway. Toxicol Mech Methods 2010;20:279-86.
94. Puga A, Hoffer A, Zhou S, Bohm JM, Leikauf GD, et al. Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem Pharmacol 1997;54:1287-96.
95. Sadhu DN, Merchant M, Safe SH, Ramos Ks. Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo[a]pyrene. Arc Biochem Biophys 1993;300:124-31.
96. Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, et al. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 2000;59:65-85.
97. Kim KY, Kim DS, Lee SK, Lee IK, Chang YS, et al. Association of low-dose exposure to persistent organic pollutants with global DNA hypomethylation in healthy Koreans. Environ Health Perspect 2010;118:370-4.
98. Lee KL. Mitochondrial dysfunction and insulin resistance: The contribution of dioxin-like substances. Diabetes Metab 2011;35:207-15.
99. Fierens S, Mairesse H, Heilier JF, De Burbure C, Focant JF, et al. Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: Findings in a population-based study in Belgium. Biomarkers 2003;8:529-34.
100. Remillard Rb, Bunce NJ. Linking dioxins to diabetes: Epidemiology and biologic plausibility. Environ Health Perspect 2002;110:853-8.
101. Ruzzin J, Petersen R, Meugnier E, Madsen L, Lock EJ, et al. Persistent organic pollutant exposure leads to insulin resistance syndrome. Environ Health Perspect 2010;118: 465-71.
102. Lazar MA. How obesity causes diabetes: Not a tall tale. Science 2005;307:363-75.
103. Kriska AM, Saremi A, Hanson RL, Bennett PH, Kobes S, et al. Physical activity, obesity and the incidence of type 2 diabetes in a high-risk population. Am J Epidemiol 2003;158:669-75.
104. Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H. Body mass index history and risk of type 2 diabetes: Results from the European prospective investigation into cancer and nutrition (EPIC)-Potsdam study. Am J Clin Nutr 2006;84:427-33.
105. Wilson PW, Anderson KM, Kannel WB. Epidemiology of diabetes mellitus in the elderly. The Framingham study. Am J Med 1986;80:3-9.
106. Asia Pacific Cohort Studies Collaboration, Ni Mhurchu C, Patag V, Nakamura M, Patel A, Rodgers A, et al. Body mass index and risk of diabetes mellitus in the Asia-pacific region. Asia Pac J Clin Nutr 2006;15:127-33.
107. Cassano PA, Rosner B, Vokonas PS, Weiss ST. Obesity and body far distribution in relation to the incidence of non-insulin dependent diabetes mellitus. A prospective cohort study of men in the normative aging study. Am J Epidemiol 1992;136:1474-86.
108. Kannel WB. Lipids, diabetes, and coronary heart disease: Insights from the Framingham study. Am Heart J 1985;110:1100-7.
109. Abdullah A, Stoelwinder J, Shortreed S, Wolfe R, Stevenson C, et al. The duration of obeisity and risk of type 2 diabetes. Public Health Nutr 2011;14:119-26.
110. Alonso-Magdelena P, Morimoto S, Rippol C, Fuentes E, Nadal A. The estrogenic effect of bisphenol a disrupts pancreatic beta cell function in vivo and induces insulin resistance. Environ Health Perspect 2006;114:106-12.
111. Lee DH, Steffes MW, Sjoden A, Jones RS, Needham LL, et al. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One 2011;6:e15977.
112. Kortenkamp A. Ten years of mixing cocktails: A review of combination effects of endocrine disrupting chemicals. Environ Health Perspect 2007;115:98-105.
113. Biddinger SB, Kahn CR. From mice to men: Insights into the insulin resistance syndromes. Am Rev Physiol 2006;68: 123-58.
114. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005;307:384-7.
115. Ibrahim MM, Fjaere E, Lock EJ, Navill E, Amlund H, et al. Chronic consumption of farmed salmon containing persistent organic pollutants causes insulin resistance and obesity in mice. PLos One 2011;6:e25170.
116. Chen SC, Liao TL, Wei YH, Tzeng CR, Kao SH. Endocrine disruptor, dioxin (TCDD)-induced mitochondrial dysfunction and apoptosis in human trophoblast-like JAR cells. Mol Hum Reprod 2010;16:361-72.
117. Dirinik E, Jorens PG, Covaci A, Geens T, Roosens L, et al. Obesity and persistent organic pollutants: Possible obesogenic effect of organochlorine pesticides and polychlorinated biphenyls. Obesity 2011;19:709-14.
118. Becerra V, Odermatt J. Detection and quantification of traces of bisphenol a and bisphenol S in paper samples using analytical pyrolysis GC/MS. Analyst 2012;137:2250-9.
119. Schwartz AW, Landrigan PJ. Bisphenol A in thermal paper receipts: An opportunity for evidence-based prevention. Environ Health Perspect 2012;120:A14-5.
120. Zhu FD, Choo KH, Chang HS, Lee B. Interaction of bisphenol a with dissolved organic matter in extractive and adsorptive removal processes. Chemosphere 2012;87:857-64.
121. Zalko K, Jacques C, Duplan H, Bruel S, Perdu E. Viable skin efficiency absorbs and metabolizes bisphenol A. Chemosphere 2011;82:424-30.
122. Heudorf U, Mersch-Sundermann V, Angerer J. Phthalates: Toxicology and exposure. Int J Hyg Environ Health 2007;210:623-34.
123. Howard PH, Banerjee S, Robillard KH. Measurement of water solubilities, octanol/water partition coefficients and vapor pressures of commercial phthalate esters. Environ Toxicol Chem 1985;4:653-61.
124. van Baal P, Engelfriet PM, Boshuizen HC, van de Kassteele J, Schellevis FG, et al. Co-occurrence of diabetes, myocardial infarction, stroke and cancer: Quantifying age patterns in the Dutch population using health survey data. Popul Health Metr 2011;9:51-60.
125. Boas M, Frederiksen H, Feldt-Rasmussen U, Skakkebaek NE, Hegedus L, et al. Childhood exposure to phthalates: Associations with thyroid function, insulin-like growth factor I and growth. Environ Health Perspect 2010;118:1458-64.
126. Svensson K, Hernandez-Ramirez RU, Burguete-Garcia A, Cebrian ME, Needham LL, et al. Phthalate exposure associate with self-reported diabetes among Mexican women. Environ Res 2011;111:792-96.
127. Teitelbaum SL, Mervish N, Moshier EL, Vangeepuran N, Galvez MP, et al. Associations between phthalate metabolite urinary concentrations and body size measures in New York City children. Environ Res 2012;112:186-93.
128. Hatch EE, Nelson JW, Quershi MM, Weinberg J, Moore LL, et al. Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: A cross-sectional study of NHANES data 1999-2002. Environ Health 2008;7:27.
129. Andersen ZJ, Raaschou-Nielsen O, Ketzel M, Jensen SS, Hvidberg M, et al. Diabetes incidence and long-term exposure to air pollution: A cohort study. Diabetes Care 2012;35:92-8.
130. Carman KR, Means JC. Assessment of PAH composition of diesel fuel sorbed to marine sediments and their toxicity to aquatic food webs. OCS Study MMS 98-0057. New Orleans, LA: US Department of Interior, Minerals Management Service, Gulf of Mexico OCS Region, 1998.
131. Essumang DF. Distribution, levels and risk assessment of polycyclic aromatic hydrocarbons (PAHs) in some water bodies alont the coastal belt of Ghana. Scientific World J 2010;10:972-85.
132. Perleberg UR, Keys DA, Fisher JW. Development of a physiologically based pharmacokinetic model for decane, a constituent of jet propellant-8. Inhal Toxicol 2004;16:771-83.
133. Gangwar J, Gupta T, Gupta S, Agarwal AK. Emissions from diesel versus biodiesel fuel used in a CRDI SUV engine: PM mass and chemical composition. Inhal Toxicol 2011;23:449-58.
134. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: A systematic review and meta-analysis. J Am Med Assoc 2007;298:2654-64.
135. Hayashino Y, Fukuhara S, Okamura T, Yamato H, Tanaka H, et al. A prospective study of passive smoking and risk of diabetes in a cohort of workers: The high-risk and population strategy for occupational health promotion (HIPOP-OHP) study. Diabetes Care 2008;31:732-4.
136. Guerin MR, Jenkins RA, Tomkins BA. The chemistry of environmental tobacco smoke: Composition and measurement. Chelsea, MI: Lewis Publishers, 1992.
137. de Vries ACJ, Cohen LH. Different effects of hypolipidemic drugs pravastatin and lovastatin on the cholesterol biosynthesis of the human ocular lens in organ culture and on the cholesterol content of the rat lens in vivo. Biochim Biophys Acta 1993;1167:63-9.
138. Hamelin BA, Turgeon J. Hydrophilicity/lipophilicity: Relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol Sci 1998;19:26-37.
139. Devlin AM, Ngai YF, Ronsley R, Panagiotopoulos C. Cardiometabolic risk and MTHFR C677T variant in children treated with second-generation antipsychotics. Trans Psychiatry 2012;2:e71.
140. US EPA. Dioxins and furans, 2011. Available at: Http://www. epa.gov.pbt/pubs/dioxins.htm.
141. US EPA. Aldrin/dieldrin, 2011. Available at: Http://www.epa. gov.pbt/pubs/aldrin.htm.
142. US EPA. DDT, 2011. Available at: Http://www.epa.gov.pbt/pubs/ddt.htm.
143. US EPA. Chlordane, 2011. Available at: Http://www.epa.gov/ttnatw01/hltef/ chlordane.html.
144. US EPA. Hexachlorobenzene, 2011. Available at: Http://www. epa.gov/ttnatw01/hltef/hexa-ben.html.
145. US EPA. Mirex, 2011. Available at: Http://www.epa.gov.pbt/pubs/mirex.htn.
146. Lind PM, van Bavel B, Salihovic S, Jind L. Circulating levels of persistent organic pollutants (POPs) and carotid atherosclerosis in the elderly. Environ Health Perspect 2012;120:38-43.
147. Ha MH, Lee DH, Son HK, Park SK, Jacobs DR Jr. Association between serum hypertension: Results from the National Health and Nutrition Examination Survey 1999-2002. J Hum Hypertens 2009;23:274-86.
148. Wellenius GA, Burger MR, Brent A, Coull A, Schwartz J, et al. Ambient air pollution and the risk of acute ischemic stroke. Arch Int Med 2012;172:229-34.
149. Sergeev AV, Carpenter DO. Exposure to persistent organic pollutants increases hospitalization rates for myocardial infarction with comorbid hypertension. Prim Prev Insights 2010;2:1-9.
150. Snyder MJ, Mulder EP. Environmental endocrine disruption in decapod crustacean larvae: Hormone titers, cytochrome P 450, and stress protein responses to heptachlor exposure. Aquat Toxicol 2001;55:177-90.
151. US EPA. Health effects of PCBs, 2008. Available at: Http://www. epa.gov/osw/hazard/tsd/pcbs/pubs/effects.htm. Accessed on 20 December 2012.
152. Nishijo M, Tawara K, Nakagawa H, Honda R, Kido T, et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin in maternal breast milk and newborn head circumference. J Expo Sci Environ Epidemiol 2008;18:246-51.
153. Global Programme of Action for the Protection of the Marine Environment from Land-Based Activities, 2001. Dioxins and furans. Available at: Http://www.chem.unep.ch/gpa-trial/1-10dio.htm. Accessed on 20 December 2012.
154. Colborn T, Dumanoski D, Myers JP. Our Stolen Future. New York, NY: Penguin Books, 1997.
155. Zoller U, Hushan M. Synergistic ecotoxicity of APEOs-PAHs in rivers and sediments: Is there a potential health risk ? Rev Environ Health 2010;25:351-7.
156. Cebecauer L, Radikova Z, Rovensky J, Imrich R, Ksinantova L, et al. Increased prevalence and coincidence of antinuclear and antithyroid antibodies in the population exposed to high levels of polychlorinated pollutants cocktails. Endocr Regul 2009;43:75-81.
157. Noakes PS, Taylor P, Wilkinson S, Prescott SL. The relationship between persistent organic pollutants in maternal and neonatal tissues and immune responses to allergens: A novel exploratory study. Chemosphere 2006;63:1304-11.
158. Tryphonas H. The impact of PCBs and dioxins on children's health: Immunological considerations. Can J Pub Health 1998;89:S49-52, S54-7.
159. Fitzgerald EF, Shrestha S, Gomez MI, McCaffrey RJ, Zimmerman EA, et al. Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and neuropsychological status among older adults in New York. Neurotoxicology 2012;33:8-15.
160. Lee DH, Steffes M, Jacobs DR Jr. Positive associations of serum concentration of polychlorinated biphenyls or organochlorine pesticides with self-reported arthritis, especially rheumatoid type, in women. Environ Health Perspect 2007;115:883-8.
161. De Roos AJ, Cooper GS, Alvanja MC, Sandler DP. Rheumatoid arthritis among women in the Agricultural Health Study: Risk associated with farming activities and exposures. Ann Epidemiol 2005;15:762-70.
162. Do Y, Lee DK. Effects of polychlorinated biphenyls on the development of neuronal cells in growth period: Structure activity relationship. Exp Neurobiol 2012;21:30-6.
163. Wigle DT, Arbuckle TE, Turner MC, Berube A, Yang Q, et al. Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants. J Toxicol Environ Health B Crit Rev 2008;11:373-517.
164. Lee DH, Jacobs DR Jr, Steffes M. Association of organochlorine pesticides with peripheral neuropathy in patients with diabetes or impaired fasting glucose. Diabetes 2008;57: 3108-11.
165. Pellacani C, Tagliaferri S, Caglieri A, Goldoni M, Giordano G, et al. Synergistic interactions between PBDEs and PCBs in human neuroblastoma cells. Environ Toxicol 2012. DOI: 10.1002/tox.21768 [Epub ahead of print].
166. Tilson HA, Kodavanti PR. Neurochemical effects of polychlorinated biphenyls: An overview and identification of research needs. Neurotoxicology 1997;18:727-43.
167. Boersma ER, Lanting CI. Environmental exposure to polychlorinated biphenyls (PCBs) and dioxins. Consequences for long-term neurological and cognitive development of the child lactation. Adv Exp Med Biol 2000;478:271-87.
168. Roze E, Meijer L, Bakker A, Van Braecel KN, Bruggin K, et al. Prenatal exposure to organohalogens, including brominated flame retardants, influences motor, cognitive, and behavioral performance at school age. Environ Health Perspect 2009;117:1953-8.
169. Weuve J, Pruett RC, Schwartz J, Yanosky MS, Laden F, et al. Exposure to particulate air pollution and cognitive decline in older women. Arch Int Med 2012;173:219-27.
170. Global Programme of Action for the Protection of the Marine Environment from Land-Based Activities, 2001. Aldrin and dieldrin. Available at: Http://www.chem.unep.ch/gpa-trial/11aldi.htm. Accessed on 20 December 2012.
171. Global Programme of Action for the Protection of the Marine Environment from Land-Based Activities, 2001. Toxaphene. Available at: Http://www.chem.unep. ch/gpa-trial/18toxa.htm. Accessed on 20 December 2012 .
172. Global Programme of Action for the Protection of the Marine Environment from Land-Based Activities, 2001. PCBs. Available at: Http://www.chem.unep.ch/ gpa-trial/19pcbs.htm. Accessed on 20 December 2012
173. Crinnion WJ. The role of persistent organic pollutants in the worldwide epidemic of type 2 diabetes mellitus and the possible connection to Farmed Atlantic Salmon (Salmo salar). Altern Med Rev 2011;16:301013.